TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Roche Diagnostics Scandinavia AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
557,108
|
577,034
|
638,270 |
Financial expenses |
65
|
13
|
17 |
Earnings before taxes |
16,779
|
19,135
|
22,678 |
EBITDA |
41,233
|
39,519
|
46,811 |
Total assets |
252,747
|
253,774
|
257,578 |
Current assets |
183,663
|
206,075
|
208,162 |
Current liabilities |
118,130
|
129,042
|
149,121 |
Equity capital |
130,348
|
122,426
|
107,986 |
- share capital |
9,000
![]() |
9,000
![]() |
9,000 |
Employees (average) |
97
![]() |
97
|
105 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
51.6%
|
48.2%
|
41.9% |
Turnover per employee |
5,743
|
5,949
|
6,079 |
Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.6% |
Return on assets (ROA) |
6.7%
|
7.5%
|
8.8% |
Current ratio |
155.5%
|
159.7%
|
139.6% |
Return on equity (ROE) |
12.9%
|
15.6%
|
21.0% |
Change turnover |
-19,926
|
-61,236
|
30,388 |
Change turnover % |
-3%
|
-10%
|
5% |
Chg. No. of employees |
0
|
-8
|
4 |
Chg. No. of employees % |
0%
|
-8%
|
4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.